NEW ORLEANS — The Blood Center is urgently seeking blood and platelets during the Thanksgiving holiday break. Special donation hours have been scheduled for Saturday, Nov. 29 and Sunday, Nov. 30.

Lumia 2 is a set of new wearable smart earrings that are designed to track blood flow to bring users health insights that they won’t get from other wearable devices. The earrings can also track ...

Big Ten schools are competing in the second annual We Give Blood drive to earn $1 million for health initiatives. Wisconsin and Nebraska are leading the conference, with Wisconsin ahead at roughly ...

Amidst a host of period tracking apps out there like Flo and Natural Cycles, menstrual health startup Joii is promising something new: measuring period blood volume with AI to diagnose conditions like ...

It is not clear how far the gift will go toward covering the salaries of the nation’s 1.3 million troops. By Greg Jaffe Reporting from Washington President Trump said that an anonymous private donor ...

The Trump administration plans to funnel a $130 million donation from an anonymous ally of President Donald Trump toward paying military service members during the government shutdown, the Defense ...

WASHINGTON, D.C. -- The Trump administration plans to funnel a $130 million donation from an anonymous ally of President Donald Trump toward paying military service members during the government ...

The Trump administration plans to funnel a $130 million donation from an anonymous ally of President Donald Trump toward paying military service members during the government shutdown, the Defense ...

Scientists have converted the blood type of a donor kidney and transplanted the organ into a person. The procedure — the first of its kind — could improve access to donor organs, specialists say, ...

Pivekimab sunirine (PVEK) targets CD123, showing promise in treating BPDCN, a rare aggressive blood cancer with limited treatment options. The CADENZA trial reported a 70% complete remission rate in ...

Oct 3 (Reuters) - Rocket Pharmaceuticals (RCKT.O), opens new tab said on Friday it has withdrawn its application for U.S. approval of its experimental gene therapy for a rare inherited blood disorder.